BridgeMD
New treatment option for Terminal Illness
Official title DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
ClinicalTrials.gov ID: NCT06615349
What this study is testing
- What it's testing
- The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on the smartphone asking the patients about their symptoms and giving tips, can reduce unplanned hospital readmissions and improve well-being in advanced cancer and severely ill patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services
- Estimated life expectancy \ 3 months
- Karnofsky Index ≥ 50% / ECOG≤ 2
- Aged \>18 years
- Owns and uses a smartphone
You likely can't join if
- Patients under curative treatment
- Relevant cognitive impairment
See the full eligibility criteria
- Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services
- Estimated life expectancy \ 3 months
- Karnofsky Index ≥ 50% / ECOG≤ 2
- Aged \>18 years
- Owns and uses a smartphone
- Give written informed consent
- Patients under curative treatment
- Relevant cognitive impairment
The study team makes the final eligibility decision.
Where it's taking place
- Zurich, Canton of Zurich, Switzerland
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zurich, Canton of Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.